Tempus AI stock downgraded by William Blair
Tempus AI shares soared to an all-time high Thursday as the tech firm announced a collaboration with the nonprofit Institute ...
We recently published a list of 10 Firms Post Double-Digit Gains on Thursday. In this article, we are going to take a look at ...
Tempus AI product lines work in concert with one another, creating a pinwheel effect as they generate data, making it more valuable over time. The company launched its 'AI-enabled personal ...
Hosted on MSN15h
Artera partners with Tempus to expand AI cancer test accessArtera and Tempus are collaborating to expand access to Artera’s AI-based prostate cancer test. Currently connected to more ...
Tempus AI is at the forefront of AI-driven healthcare, using machine learning to analyze vast clinical datasets and enhance personalized medicine. By streamlining diagnostics and treatment plans ...
The more significant driver of Tempus’ rally was the announcement of its new AI-enabled health app, Olivia. Designed as a personal health concierge, Olivia integrates patient data from over ...
Tempus AI shares surged more than 35% on Tuesday after former House Speaker Nancy Pelosi disclosed call options expiring in 2026. Several AI-related stocks are rising Wednesday after U.S ...
Tempus AI, Inc (NASDAQ:TEM) is soaring as investors get behind former House Speaker Nancy Pelosi's latest stock purchase. Yet, as we go through and discuss the setup here, I contend that investors ...
Whales with a lot of money to spend have taken a noticeably bearish stance on Tempus AI. Looking at options history for Tempus AI (NASDAQ:TEM) we detected 21 trades. If we consider the ...
Shareholders in Tempus AI, Inc. (NASDAQ:TEM) may be thrilled to learn that the analysts have just delivered a major upgrade to their near-term forecasts. The consensus estimated revenue numbers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback